Affected by favorable factors such as industrial Internetization, population aging, and national policy support, China's medical and health industry is entering a golden period of development.
In the context of economic downturn, benefiting from the small impact of the economic cycle, the advantages of the medical and health industry are more prominent. In 2016, the medical and health industry remained the main battlefield of capital layout. According to statistics, as of the end of November 2016, the number of investment events in the medical and health industry ranked fifth among all industries.
Recently, the "2016 China Medical Device Industry Investment and Financing Blue Book" (hereinafter referred to as the Blue Book) released at the 76th China Medical Devices (Autumn) Expo shows that from 2013 to 2015, the investment and financing of the domestic medical device market has become increasingly active, and the number of investments And the transaction amount is rising rapidly. In 2015, there were about 80 medical device M&A transactions (excluding overseas M&A) in the domestic market, which was 78% higher than the 45 in 2013. According to statistics, the total transaction volume in 2015 was about 2.9 billion US dollars, far exceeding the 1.1 billion US dollars in 2013, an increase of 164%.
Compared with other industries, in the same stage, the medical and health industry project financing amount is relatively large. In addition to the reason that the industry project itself is generally high in valuation, the medical and health industry has the characteristics of making money slowly and making money difficult. It is generally difficult for startup companies. The rapid formation of scale, so investors gave the startup a lot of money to prepare for a cold start. “The capital market tends to be rational. If you want to make quick money, don’t touch medical treatment.†At the launching ceremony of the 2017 Medical Industry Investment and Financing Forum and Medical Device Technology Innovation Incubation Platform and Medical Development Investment Management Service Platform, Liu Mingyu, a partner of Zhongxing Hechuang, pointed out.
Entering the golden age
China's medical device industry is still in the early stage of development. Driven by the capital of mergers and acquisitions, the number of domestic investment M&A transactions will maintain a relatively fast growth rate. The Blue Book points out that in the context of national policy support, active investor participation, and growing market demand, the domestic medical device industry will enter a golden age of rise.
Wang Baoting, former director of the Medical Devices Division of the State Food and Drug Administration and deputy secretary-general of the China Drug Supervision and Management Association, also agrees that “the next decade will be the golden stage for the rapid development of China's medical device industry. †“Innovative medical device products will continue to emerge in the future. In particular, innovative medical devices that replace imports will speed up the listing, and we hope that everyone will reduce operational and investment risks through multiple considerations."
Wenzhou Celecare Medical Instruments Co.,Ltd , https://www.celecaremed.com